Literature DB >> 12720081

A girl with rickets and nephrocalcinosis.

Nathalie Godefroid1, Willem Proesmans.   

Abstract

A 5-year-old girl presented with short stature. She was found to have rickets due to renal phosphate wasting and nephrocalcinosis. Serum parathyroid hormone was suppressed, 25-OH vitamin D was within the normal range, and 1,25-(OH)(2 )vitamin D was elevated. In addition, she had hypercalciuria, proteinuria, which was partially tubular in origin, and a reduced glomerular filtration rate of 58 ml/min per 1.73 m(2). Treatment with phosphate supplements resulted in healing of the rickets and normalization of the serum 1,25-(OH)(2 )vitamin D level. This patient is an example of hypercalciuric rickets, most likely due to an inherited disorder of phosphate metabolism. Hypercalciuric rickets can be inherited as an autosomal recessive as well as autosomal dominant trait.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12720081     DOI: 10.1007/s00467-003-1140-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  12 in total

1.  A second family with XLRH displays the mutation S244L in the CLCN5 gene.

Authors:  C Oudet; D Martin-Coignard; S Pannetier; E Praud; G Champion; A Hanauer
Journal:  Hum Genet       Date:  1997-06       Impact factor: 4.132

2.  Autosomal recessive hypophosphataemic rickets with hypercalciuria is not caused by mutations in the type II renal sodium/phosphate cotransporter gene.

Authors:  L van den Heuvel; K Op de Koul; E Knots; N Knoers; L Monnens
Journal:  Nephrol Dial Transplant       Date:  2001-01       Impact factor: 5.992

3.  FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate.

Authors:  A E Bowe; R Finnegan; S M Jan de Beur; J Cho; M A Levine; R Kumar; S C Schiavi
Journal:  Biochem Biophys Res Commun       Date:  2001-06-22       Impact factor: 3.575

4.  Dent's disease; a familial proximal renal tubular syndrome with low-molecular-weight proteinuria, hypercalciuria, nephrocalcinosis, metabolic bone disease, progressive renal failure and a marked male predominance.

Authors:  O M Wrong; A G Norden; T G Feest
Journal:  QJM       Date:  1994-08

5.  Hereditary hypophosphatemic rickets with hypercalciuria.

Authors:  M Tieder; D Modai; R Samuel; R Arie; A Halabe; I Bab; D Gabizon; U A Liberman
Journal:  N Engl J Med       Date:  1985-03-07       Impact factor: 91.245

6.  Mice lacking renal chloride channel, CLC-5, are a model for Dent's disease, a nephrolithiasis disorder associated with defective receptor-mediated endocytosis.

Authors:  S S Wang; O Devuyst; P J Courtoy; X T Wang; H Wang; Y Wang; R V Thakker; S Guggino; W B Guggino
Journal:  Hum Mol Genet       Date:  2000-12-12       Impact factor: 6.150

Review 7.  Pathogenesis of Dent's disease and related syndromes of X-linked nephrolithiasis.

Authors:  R V Thakker
Journal:  Kidney Int       Date:  2000-03       Impact factor: 10.612

8.  Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23.

Authors: 
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

9.  Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder.

Authors:  M J Econs; P T McEnery
Journal:  J Clin Endocrinol Metab       Date:  1997-02       Impact factor: 5.958

10.  Genetic mapping in the Xp11.2 region of a new form of X-linked hypophosphatemic rickets.

Authors:  A Bolino; M Devoto; G Enia; C Zoccali; J Weissenbach; G Romeo
Journal:  Eur J Hum Genet       Date:  1993       Impact factor: 4.246

View more
  2 in total

1.  Dent disease with compound heterozygous mutations leading to severe chronic renal failure in a female patient.

Authors:  Martin Holder; Martin Bald; Heinz E Leichter; Michael Ludwig
Journal:  Pediatr Nephrol       Date:  2003-11-25       Impact factor: 3.714

2.  Family history may be misleading in the diagnosis of Dent's disease.

Authors:  F Anglani; P Bernich; E Tosetto; M Cara; A Lupo; F Nalesso; A D'Angelo; G Gambaro
Journal:  Urol Res       Date:  2006-01-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.